Publications

2011

NUMB does not impair growth and differentiation status of experimental gliomas.

Euskirchen P, Skaftnesmo KO, Huszthy PC, Brekka N, Bjerkvig R, Jacobs AH, Miletic H. 2011 Dec. Exp Cell Res.317(20):2864-73. Epub 2011 Sep 12.

Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.

Svendsen A, Verhoeff JJ, Immervoll H, Brogger JC, Kmiecik J, Poli A, Netland IA, Prestegarden L, Planaguma J, Torsvik A, Kjersem AB, Sakariassen PO, Heggdal JI, Van Furth WR, Bjerkvig R, Lund-Johansen M, Enger PO, Felsberg J, Brons NH, Tronstad KJ, Waha A, Chekenya M. 2011 Oct. Acta Neuropathol.122(4):495-510. Epub 2011 Aug 24.

Novel ways to target brain tumour metabolism.

Stieber D, Abdul Rahim SA, Niclou SP. 2011 Oct. Expert Opin Ther Targets.5(10):1227-39. Epub 2011 Jun 2.

Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.

Wang J, Svendsen A, Kmiecik J, Immervoll H, Skaftnesmo KO, Planaguma J, Reed RK, Bjerkvig R, Miletic H, Enger PO, Rygh CB, Chekenya M. 2011 Jul. PLoS One.6(7):e23062. Epub 2011 Jul 29.

Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma.

Atai NA, Renkema-Mills NA, Bosman J, Schmidt N, Rijkeboer D, Tigchelaar W, Bosch KS, Troost D, Jonker A, Bleeker FE, Miletic H, Bjerkvig R, De Witt Hamer PC, Van Noorden CJ. 2011 May. J Histochem Cytochem.59(5):489-503. Epub 2011 Feb 10.

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.

Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, Miletic H, Wang J, Stieber D, Stuhr L, Moen I, Rygh CB, Bjerkvig R, Niclou SP. 2011 Mar. Proc Natl Acad Sci U S A.108(9):3749-54. Epub 2011 Feb 14.

Critical appraisal of the side population assay in stem cell and cancer stem cell research.

Golebiewska A, Brons NH, Bjerkvig R, Niclou SP. 2011 Feb. Cell Stem Cell.8(2):136-47.

A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients.

Wang J, Daphu I, Pedersen PH, Miletic H, Hovland R, Mork S, Bjerkvig R, Tiron C, McCormack E, Micklem D, Lorens JB, Immervoll H, Thorsen F. 2011 Feb. Neuropathol Appl Neurobiol.37(2):189-205.